General Electric is selling its biopharma business to Danaher Corp. for $21.4 billion as it continues to sell off chunks of a once sprawling conglomerate, per the AP . The biopharma unit, part of GE Life Sciences, generated revenue of about $3 billion last year. In fact, the Wall Street...
General Electric is selling its biopharma business to Danaher Corp. for $21.4 billion as it continues to sell off chunks of a once sprawling conglomerate, per the AP . The biopharma unit, part of GE Life Sciences, generated revenue of about $3 billion last year. In fact, the Wall Street...